Prospector Partners LLC Grows Stock Position in Cigna Group $CI

Prospector Partners LLC boosted its stake in shares of Cigna Group (NYSE:CI) by 14.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,072 shares of the health services provider’s stock after acquiring an additional 4,163 shares during the quarter. Prospector Partners LLC’s holdings in Cigna Group were worth $9,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Pathway Financial Advisers LLC boosted its stake in shares of Cigna Group by 2.3% during the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after purchasing an additional 34 shares during the period. Armstrong Advisory Group Inc. raised its holdings in Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares during the last quarter. HM Payson & Co. boosted its position in Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after buying an additional 35 shares during the period. Carr Financial Group Corp boosted its position in Cigna Group by 5.3% during the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after buying an additional 36 shares during the period. Finally, Natural Investments LLC grew its holdings in Cigna Group by 2.0% in the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after acquiring an additional 36 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of analyst reports. Truist Financial increased their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday. Morgan Stanley reiterated an “overweight” rating and issued a $355.00 price objective on shares of Cigna Group in a report on Friday, October 31st. Deutsche Bank Aktiengesellschaft raised their price target on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Wells Fargo & Company dropped their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $330.63.

Cigna Group Stock Down 0.2%

Shares of Cigna Group stock opened at $290.24 on Thursday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm has a market cap of $77.53 billion, a price-to-earnings ratio of 13.09, a PEG ratio of 1.01 and a beta of 0.27. The company has a 50-day moving average of $278.52 and a 200 day moving average of $283.99. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter in the prior year, the company earned $6.64 earnings per share. The business’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 27.23%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.